Implantable devices are an emerging option for patients with medically refractory epilepsy who are not surgical candidates.
Lauren Elman, MD
Treating adult patients with antisense oligonucleotide therapy proven effective in children presents unique challenges.
Ira M. Turner, MD
Should you provide outpatient infusion when a patientâ€™s usual acute migraine therapy doesnâ€™t work?
Javed Khader Eliyas, MD; Karen S. SantaCruz, MD; and Rimas V. Lukas, MD